POLR1A
protein-codingRNA polymerase I subunit A, the group of RNA polymerase subunits
Gene summary
The protein encoded by this gene is the largest subunit of the RNA polymerase I complex. The encoded protein represents the catalytic subunit of the complex, which transcribes DNA into ribosomal RNA precursors. Defects in this gene are a cause of the Cincinnati type of acrofacial dysostosis. [provided by RefSeq, May 2016]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~85.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0014651
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0958018
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0012064
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0014651
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0014651
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0014651
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0958018
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to POLR1A variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_015425.6. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 8 | 276 | 9 | 293 | ||
| missense | 2 | 2 | 581 | 31 | 7 | 623 |
| nonsense | 1 | 2 | 14 | 17 | ||
| start loss | 0 | |||||
| frameshift | 1 | 4 | 6 | 11 | ||
| splice donor/acceptor (+/-2bp) | 13 | 13 | ||||
| Total | 4 | 8 | 622 | 307 | 16 | 957 |
Highest pathogenic variant AF is 0.0000054772913
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_056240.2 | 34 | MANE Select | |
| Ensembl | ENSP00000263857.6 | 34 | MANE Select | |
| Ensembl | ENSP00000386423.3 | 2 | Standard | |
| Ensembl | ENSP00000386300.1 | 34 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| polr1a | Danio rerio | Structure: melanocyte Quality: quality abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Pyrimidine metabolism - Homo sapiens (human)
- RNA polymerase - Homo sapiens (human)
- Purine metabolism - Homo sapiens (human)
- Nucleotide Excision Repair
- Pyrimidine metabolism
Biological Process
- transcription initiation from RNA polymerase I promoter
- termination of RNA polymerase I transcription
- positive regulation of gene expression, epigenetic
- negative regulation of protein localization to nucleolus
Molecular Function
- RNA polymerase I activity
- DNA binding
- chromatin binding
- DNA-directed 5'-3' RNA polymerase activity
- protein binding
Cellular Component
- nucleoplasm
- RNA polymerase I complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000263857
- Coding exons
- 34
- Length
- 85940
- Individuals with no LoFs
- 124765
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 49
- Defined
- 124814
- p
- 0.000196
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.95 | 750 | 1.01e+3 | 0.739 | 0.0000612 | 11278 |
| Missense (PolyPhen) | 268 | 497.29 | 0.53892 | 5537 | ||
| Synonymous | 1.03 | 394 | 421 | 0.936 | 0.0000277 | 3345 |
| Loss of Function | 7.50 | 16 | 94.8 | 0.169 | 0.00000546 | 1027 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00013 | 0.00013 | rare |
| Latino/Admixed American | 0.00036 | 0.00035 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00017 | 0.00017 | rare |
| Finnish | 0.00023 | 0.00023 | rare |
| European (Non-Finnish) | 0.00013 | 0.00013 | rare |
| South Asian | 0.00039 | 0.00039 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Largest and catalytic core component of RNA polymerase I which synthesizes ribosomal RNA precursors. Forms the polymerase active center together with the second largest subunit. A single stranded DNA template strand of the promoter is positioned within the central active site cleft of Pol I. A bridging helix emanates from RPA1 and crosses the cleft near the catalytic site and is thought to promote translocation of Pol I by acting as a ratchet that moves the RNA-DNA hybrid through the active site by switching from straight to bent conformations at each step of nucleotide addition (By similarity). {ECO:0000250|UniProtKB:P10964}.;
- Disease
- DISEASE: Acrofacial dysostosis, Cincinnati type (AFDCIN) [MIM:616462]: A form of acrofacial dysostosis, a group of disorders which are characterized by malformation of the craniofacial skeleton and, in some patients, the limbs. {ECO:0000269|PubMed:25913037}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.220
Intolerance Scores
- LoFtool
- 0.404
- RVIS EVS
- 0.09
- RVIS percentile EVS
- 60.33
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- N
- Indispensability score
- 0.379
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |